NFKBID: A Key Regulator of Immune and Cellular Signaling Pathways

Target Name: NFKBID

NCBI ID: G84807

NFKBID

NFKBID: A Key Regulator of Immune and Cellular Signaling Pathways

The nervous system is a complex and crucial part of the human body, and it is responsible for controlling and coordinating all the body's functions. The nervous system is made up of a network of neurons and their associated synapses, and it is responsible for transmitting electrical signals throughout the body. One of the key proteins that helps to regulate and control the nervous system is the ikapalapant-conjugated K-channel subfamily (IKAP) protein, also known as NFKBID (IkappaBNS).

The NFKBID protein is a key regulator of the immune response and has been shown to play a crucial role in the regulation of inflammation and pain. It is made up of four subunits, each of which has a unique function in regulating the immune response and controlling the spread of infection. The four subunits of NFKBID are NFKB1, NFKB2, NFKB3, and NFKB4.

NFKB1 is the most abundant subunit and is responsible for regulating the immune response to infection. It is also involved in the regulation of inflammation and has been shown to play a key role in the development of chronic pain. NFKB2 is involved in the regulation of cell death and has been shown to play a key role in the regulation of the immune response and the development of cancer. NFKB3 is involved in the regulation of inflammation and has been shown to play a key role in the development of autoimmune diseases. NFKB4 is the least abundant subunit and is involved in the regulation of the immune response and has been shown to play a key role in the regulation of inflammation.

The NFKBID protein is also involved in the regulation of cellular signaling pathways and has been shown to play a key role in the regulation of cell signaling pathways. It is also involved in the regulation of the production of inflammatory cytokines and has been shown to play a key role in the regulation of inflammation.

In addition to its role in regulating the immune response and the regulation of inflammation, the NFKBID protein is also involved in the regulation of pain. It is shown to play a key role in the regulation of pain perception and has been shown to play a key role in the development of chronic pain.

The NFKBID protein is also involved in the regulation of cellular signaling pathways and has been shown to play a key role in the regulation of cell signaling pathways. It is also involved in the regulation of the production of inflammatory cytokines and has been shown to play a key role in the regulation of inflammation.

In conclusion, the NFKBID protein is a key regulator of the immune response and has been shown to play a crucial role in the regulation of inflammation and pain. It is a potential drug target and may be useful in the treatment of a variety of diseases.

Protein Name: NFKB Inhibitor Delta

Functions: Regulates the expression of IL-2, IL-6, and other cytokines through regulation on NF-kappa-B activity. Functions in the regulation of inflammatory responses. Involved in the induction of T helper 17 cells (Th17) differentiation upon recognition of antigen by T cell antigen receptor (TCR). May also regulate TCR-induced negative selection of thymocytes

The "NFKBID Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about NFKBID comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets